Visual function following transpupillary thermotherapy with adjusted laser parameters for the treatment of exudative age-related macular degeneration: a pilot study

被引:4
|
作者
Tranos, P
Peter, NM
Nath, R
Singh, MV
Wren, S
Dimitrakos, S
Rassam, S
Kon, C
机构
[1] Worthing Gen Hosp, Worthing, England
[2] AHEPA Gen Hosp, Thessaloniki, Greece
来源
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2006年 / 34卷 / 03期
关键词
age-related macular degeneration; choroidal neovascularization; transpupillary thermotherapy;
D O I
10.1111/j.1442-9071.2006.01198.x
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the efficacy of transpupillary thermotherapy (TTT) using adjusted laser parameters for the treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration. Methods: TTT was performed on patients with CNV using a diode laser (810 nm) for 60 s in a subthreshold manner. Power settings were varied between 460 and 1200 mW, depending on lesion size, presence of pigment epithelial detachment and the amount of fundal pigmentation and subretinal fluid. LogMAR visual acuity, contrast sensitivity (Pelli-Robson) and metamorphopsia (Amsler chart) were assessed prior to and 6 months following treatment. Subjects also self-administered the National Eye Institute 25-Item Visual Function Questionnaire. Results: Thirty occult/minimally classic and eight predominantly classic membranes were treated with TTT. At 6 months, absence or significant reduction of fluorescein leakage was observed in 20 (53%) patients. Stabilization of vision (loss of less than 15 letters) was observed in 25/30 (83%) eyes with occult/minimally classic CNV and 5/8 (63%) eyes with predominantly classic CNV. Improvement of contrast sensitivity was noted in 15 (35%) eyes, in 10 (26%) eyes it remained unchanged and in 13 (34%) eyes it deteriorated. There was no statistically significant effect of TTT on the National Eye Institute 25-Item Visual Function Questionnaire composite or subscale scores. Conclusions: TTT using adjusted parameters depending on fundal characteristics appears to be effective in stabilizing subjective and objective visual ability in a considerable number of patients with subfoveal CNV due to age-related macular degeneration. Larger-scale studies are required to confirm the benefit of this technique as opposed to the natural history of occult CNV.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 50 条
  • [41] Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
    Garcia-Layana, Alfredo
    Figueroa, Marta S.
    Araiz, Javier
    Ruiz-Moreno, Jose M.
    Gomez-Ulla, Francisco
    Arias-Barquet, Luis
    Reiter, Nicholas
    DRUGS & AGING, 2015, 32 (10) : 797 - 807
  • [42] Results 28 months following transpupillary thermotherapy for classic and occult choroidal neovascularization in patients with age-related macular degeneration
    Newsom, RSB
    McAlister, JC
    Saeed, M
    El-Ghonemy, K
    McHugh, JDA
    OPHTHALMIC SURGERY LASERS & IMAGING, 2005, 36 (02) : 94 - 102
  • [43] Topical nepafenac for treatment of exudative age-related macular degeneration
    Libondi, Teodosio
    Jonas, Jost B.
    ACTA OPHTHALMOLOGICA, 2010, 88 (02) : e32 - e33
  • [44] Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
    Alfredo García-Layana
    Marta S. Figueroa
    Javier Araiz
    José M. Ruiz-Moreno
    Francisco Gómez-Ulla
    Luis Arias-Barquet
    Nicholas Reiter
    Drugs & Aging, 2015, 32 : 797 - 807
  • [45] Radiation therapy in the treatment of exudative age-related macular degeneration
    Steinle, Nathan
    Barakat, Mark
    Moshfeghi, Darius
    Kaiser, Peter K.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2011, 6 (03) : 323 - 337
  • [46] Pilot study of intravitreal injection of triamcinolone acetonide in exudative age-related macular degeneration
    Moon, SJ
    Mieler, WF
    Holz, ER
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U279 - U279
  • [47] Visit Adherence and Visual Acuity in Exudative Age-Related Macular Degeneration
    Ramakrishnan, Meera S.
    VanderBeek, Brian L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [48] Drusen in Exudative Age-Related Macular Degeneration
    Yu, S. -Y.
    Cho, N. -S.
    Kim, M. -S.
    Kim, E. -S.
    Kwak, H. -W.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [49] Pegaptanib in exudative age-related macular degeneration
    Amoaku, WM
    DRUGS, 2005, 65 (11) : 1579 - 1579
  • [50] PegaptanibIn Exudative Age-Related Macular Degeneration
    M. Asif A. Siddiqui
    Gillian M. Keating
    Drugs, 2005, 65 : 1571 - 1577